Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
NCT Number: NCT00271687
This study aims to provide preliminary data on the feasibility and outcomes of a 12 week exercise program on the quality of life of men with hormone refractory prostate cancer receiving docetaxel-based chemotherapy.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 2
Edmonton, Alberta, T6G 1Z2, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AHS Cancer Control Alberta
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04790968
Genital Diseases, Genital Diseases, Male
Bergen, Norway
View Trial DetailsNCT00519285
Genital Diseases, Genital Diseases, Male
Bridgewater, New Jersey, United States
View Trial DetailsNCT05288166
Abiraterone Acetate, Androgens
Prescott, Arizona, United States
View Trial DetailsNCT07572760
Behavior, Female Urogenital Diseases
San Vicent del Raspeig, Alicante, Spain
View Trial Details